The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Caribou Biosciences Inc shares valued at $4,811 were sold by MCCLUNG BARBARA G on Feb 21 ’25. At $1.35 per share, MCCLUNG BARBARA G sold 3,564 shares. The insider’s holdings dropped to 443,502 shares worth approximately $0.53 million following the completion of this transaction.
Also, Khan Ruhi Ahmad sold 3,564 shares, netting a total of over 4,811 in proceeds. Following the sale of shares at $1.35 each, the insider now holds 66,936 shares.
Before that, Kanner Steven had sold 3,564 shares from its account. In a trade valued at $4,811, the Chief Scientific Officer traded Caribou Biosciences Inc shares for $1.35 each. Upon closing the transaction, the insider’s holdings decreased to 3,564 shares, worth approximately $0.52 million.
As published in a research note from Evercore ISI on June 03, 2024, Caribou Biosciences Inc [CRBU] has been rated down from an Outperform to an In-line and the price target has been revised to $3 from $13. Analysts at Cantor Fitzgerald started covering the stock with ‘”a Neutral”‘ outlook in a report released in early November. As of October 31, 2023, Evercore ISI has initiated its “an Outperform” rating for CRBU. Earlier on July 11, 2023, Truist initiated its rating. Their recommendation was “a Buy” for CRBU stock.
Analyzing CRBU Stock Performance
During the last five days, there has been a drop of approximately -16.08%. Over the course of the year, Caribou Biosciences Inc shares have dropped approximately -24.53%. Shares of the company reached a 52-week high of $2.0400 on 01/07/25 and a 52-week low of $1.1745 on 02/26/25. A 50-day SMA is recorded $1.5450, while a 200-day SMA reached $2.0064. Nevertheless, trading volume fell to 1.73 million shares from 1.13 million shares the previous day.
Support And Resistance Levels for Caribou Biosciences Inc (CRBU)
According to the 24-hour chart, there is a support level at 1.1663, which, if violated, would cause prices to drop to 1.1327. In the upper region, resistance lies at 1.2418. The next price resistance is at 1.2837. RSI (Relative Strength Index) is 32.73 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0879, which suggests the price will decrease in the coming days. Percent R is at 91.92%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
